Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas F. Rocereto, MD
Cancer Institute of New Jersey at Cooper - Voorhees
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente Medical Center - Los Angeles
Los Angeles, California, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Woman'S Hospital
Baton Rouge, Louisiana, United States
- Maine Medical Center - Bramhall Campus
Portland, Maine, United States
- Regional Cancer Center at Singing River Hospital
Pascagoula, Mississippi, United States
- Freeman Cancer Institute at Freeman Health System
Joplin, Missouri, United States
- Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, United States
- Methodist Estabrook Cancer Center
Omaha, Nebraska, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
- Lake/university Ireland Cancer Center
Mentor, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital
Abington, Pennsylvania, United States
- Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, United States
- Cancer Center of Paoli Memorial Hospital
Paoli, Pennsylvania, United States
- Lankenau Cancer Center at Lankenau Hospital
Wynnewood, Pennsylvania, United States
- Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States
- University of Texas Medical Branch
Galveston, Texas, United States
- Marshfield Clinic - Marshfield Center
Marshfield, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2007
- Primary completion
- 31 Jul 2010
- Completion
- 31 Jul 2010
- Last update posted
- 18 Jul 2018
- Registered enrollment
- 24
- Registry id
- NCT00459290
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.